Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Clinical trial NCT00098163 · COMPLETED
Trial details
- NCT number
- NCT00098163
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.